Literature DB >> 17692290

Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison.

Christopher R Arthur1, John T Gupton, Glen E Kellogg, W Andrew Yeudall, Myles C Cabot, Irene F Newsham, David A Gewirtz.   

Abstract

JG-03-14, a substituted pyrrole that inhibits microtubule polymerization, was screened against MCF-7 (p53 wild type), MDA-MB231 (p53 mutant), MCF-7/caspase 3 and MCF-7/ADR (multidrug resistant) breast tumor cell lines. Cell viability and growth inhibition were assessed by the crystal violet dye assay. Apoptosis was evaluated by the TUNEL assay, cell cycle distribution by flow cytometry, autophagy by acridine orange staining of vesicle formation, and senescence based on beta-galactosidase staining and cell morphology. Our studies indicate that exposure to JG-03-14, at a concentration of 500 nM, induces time-dependent cell death in the MCF-7 and MDA-MB231 cell lines. In MCF-7 cells, a residual surviving cell population was found to be senescent; in contrast, there was no surviving senescent population in treated MDA-MB231 cells. No proliferative recovery was detected over a period of 15 days post-treatment in either cell line. Both the TUNEL assay and FLOW cytometry indicated a relatively limited degree of apoptosis (<10%) in response to drug treatment in MCF-7 cells with more extensive apoptosis (but <20%) in MDA-MB231 cells; acidic vacuole formation indicative of autophagic cell death was relatively extensive in both MCF-7 and MDA-MB231 cells. In addition, JG-03-14 induced the formation of a large hyperdiploid cell population in MDA-MB231 cells. JG-03-14 also demonstrated pronounced anti-proliferative activity in MCF-7/caspase 3 cells and in the MCF-7/ADR cell line. The observation that JG-03-14 promotes autophagic cell death and also retains activity in tumor cells expressing the multidrug resistance pump indicates that novel microtubule poisons of the substituted pyrroles class may hold promise in the treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692290      PMCID: PMC2000298          DOI: 10.1016/j.bcp.2007.07.003

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  39 in total

1.  Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis.

Authors:  X H Yang; T L Sladek; X Liu; B R Butler; C J Froelich; A D Thor
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

2.  A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.

Authors:  S Paglin; T Hollister; T Delohery; N Hackett; M McMahill; E Sphicas; D Domingo; J Yahalom
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

3.  Different spindle checkpoint proteins monitor microtubule attachment and tension at kinetochores in Drosophila cells.

Authors:  Elsa Logarinho; Hassan Bousbaa; José Miguel Dias; Carla Lopes; Isabel Amorim; Ana Antunes-Martins; Claudio E Sunkel
Journal:  J Cell Sci       Date:  2004-03-16       Impact factor: 5.285

4.  Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance.

Authors:  Eswaran Devarajan; Aysegul A Sahin; Jack S Chen; Raghu R Krishnamurthy; Neeraj Aggarwal; Anne-Marie Brun; Anna Sapino; Fan Zhang; Dhawal Sharma; Xiao-He Yang; Ann D Tora; Kapil Mehta
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

5.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

Authors:  R L Juliano; V Ling
Journal:  Biochim Biophys Acta       Date:  1976-11-11

6.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

7.  A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells.

Authors:  Mordechai Liscovitch; Dana Ravid
Journal:  Cancer Lett       Date:  2006-02-28       Impact factor: 8.679

8.  Synthesis and cytotoxicity of 2,4-disubstituted and 2,3,4-trisubstituted brominated pyrroles in murine and human cultured tumor cells.

Authors:  J T Gupton; B S Burham; K Krumpe; K Du; J A Sikorski; A E Warren; C R Barnes; I H Hall
Journal:  Arch Pharm (Weinheim)       Date:  2000-01       Impact factor: 3.751

9.  Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction.

Authors:  Lynne W Elmore; Catherine W Rehder; Xu Di; Patricia A McChesney; Colleen K Jackson-Cook; David A Gewirtz; Shawn E Holt
Journal:  J Biol Chem       Date:  2002-07-05       Impact factor: 5.157

10.  Synthesis and cytotoxicity of substituted ethyl 2-phenacyl-3-phenylpyrrole-4-carboxylates.

Authors:  Michael A Evans; Daniel C Smith; Justin M Holub; Anthony Argenti; Mafoloe Hoff; Gerard A Dalglish; Donna L Wilson; Brett M Taylor; Joshua D Berkowitz; Bruce S Burnham; Keith Krumpe; John T Gupton; Tanya C Scarlett; Richard W Durham; Iris H Hall
Journal:  Arch Pharm (Weinheim)       Date:  2003-06       Impact factor: 3.751

View more
  22 in total

1.  MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells.

Authors:  Giampietro Viola; Roberta Bortolozzi; Ernest Hamel; Stefano Moro; Paola Brun; Ignazio Castagliuolo; Maria Grazia Ferlin; Giuseppe Basso
Journal:  Biochem Pharmacol       Date:  2011-09-22       Impact factor: 5.858

2.  Pyrrole-Based Antitubulin Agents: Two Distinct Binding Modalities are Predicted for C-2 Analogs in the Colchicine Site.

Authors:  Chenxiao Da; Nakul Telang; Peter Barelli; Xin Jia; John T Gupton; Susan L Mooberry; Glen E Kellogg
Journal:  ACS Med Chem Lett       Date:  2011-11-01       Impact factor: 4.345

3.  Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.

Authors:  Ariane Chan; Connie Gilfillan; Nikki Templeton; Ian Paterson; Peter T Northcote; John H Miller
Journal:  Invest New Drugs       Date:  2017-07-22       Impact factor: 3.850

4.  Colchicine induces autophagy and senescence in lung cancer cells at clinically admissible concentration: potential use of colchicine in combination with autophagy inhibitor in cancer therapy.

Authors:  Surela Bhattacharya; Amlan Das; Satabdi Datta; Arnab Ganguli; Gopal Chakrabarti
Journal:  Tumour Biol       Date:  2016-02-11

5.  Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.

Authors:  Min Huang; Patrick Whang; Patrick Lewicki; Beverly S Mitchell
Journal:  Mol Pharmacol       Date:  2011-04-04       Impact factor: 4.436

6.  Interference with endothelial cell function by JG-03-14, an agent that binds to the colchicine site on microtubules.

Authors:  Nava Dalyot-Herman; Fernando Delgado-Lopez; David A Gewirtz; John T Gupton; Edward L Schwartz
Journal:  Biochem Pharmacol       Date:  2009-07-01       Impact factor: 5.858

7.  Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins.

Authors:  Anna Litwiniec; Alina Grzanka; Anna Helmin-Basa; Lidia Gackowska; Dariusz Grzanka
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-07       Impact factor: 4.553

8.  Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells.

Authors:  Moureq Alotaibi; Khushboo Sharma; Tareq Saleh; Lawrence F Povirk; Eric A Hendrickson; David A Gewirtz
Journal:  Radiat Res       Date:  2016-03-02       Impact factor: 2.841

9.  Effects of a pyrrole-based, microtubule-depolymerizing compound on RAW 264.7 macrophages.

Authors:  John A Ciemniecki; Clarke P Lewis; John T Gupton; Krista Fischer-Stenger
Journal:  Chem Biol Interact       Date:  2016-01-11       Impact factor: 5.192

10.  Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt high-throughput flow cytometry system.

Authors:  Mark K Haynes; J Jacob Strouse; Anna Waller; Andrei Leitao; Ramona F Curpan; Cristian Bologa; Tudor I Oprea; Eric R Prossnitz; Bruce S Edwards; Larry A Sklar; Todd A Thompson
Journal:  J Biomol Screen       Date:  2009-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.